Teams at Kymera Therapeutics

Lead global and U.S. pricing, reimbursement, access, and value strategies across Kymera's pipeline. Drive payer engagement, pricing governance, evidence-generation alignment with Clinical/HEOR, launch readiness, and lifecycle access optimization. Influence cross-functional strategy, manage market access risks, and support commercial planning to maximize patient access and product value for immunology indications.

Lead global commercial strategy, brand planning, and launch readiness for KT-621. Define product vision, positioning, target segments, and value proposition. Drive launch execution, cross-functional alignment, evidence generation, market assessments, and lifecycle expansion across immunology indications. Partner with Clinical Development, Medical Affairs, Market Access, Regulatory, Finance, and Analytics to support successful US and global commercialization.

Provide strategic and operational leadership for study start-up activities in clinical programs, ensuring compliant site activation and timely execution of trial initiatives.